Back to Rankings

VTRS

ViatrisC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
VTRS vs peer average
45/100
VTRS vs. peer average (C vs. C)
Grade spread
A 1 · B 3 · C 4 · D 2
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

GILD is the first available peer comparator.

A closer large-cap commercial-pharma comparator for cash flow and capital-return discipline, though it has far less generics exposure than Viatris.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerGILDGilead Sciences
VTRS
Viatris
GILD
Gilead Sciences
Grade
C
C
Momentum
49
26
Value
66
65
Sentiment
37
51
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Mixed

Grade position vs GILD

VTRS / GILD
Grade Position
In line
VTRS vs. peer average (C vs. C)
45/100
Momentum
49
VTRS
Value
66
VTRS
Sentiment
37
GILD

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs VTRS
1
GILD
GILD
C
60/100
Even
2
AMGN
AMGN
D
40/100
+1
3
INCY
INCY
B
80/100
-1
4
UTHR
United Therapeutics Corp Common
C
60/100
Even
5
NBIX
Neurocrine Biosciences Inc Common
B
80/100
-1
GILD is the first peer returned for this comparison set.